Octane is pleased to announce the first round of selected LaunchPad SBDC alumni who will present at Aesthetics Tech Summit 2022 on January 20 - 21, 2022. These companies represent the best of the best that have graduated from Octane's LaunchPad process - a rigorous program designed to help startups and companies seeking Series A investment refine their presentation and business plan.
These four companies are at the cutting edge of medical aesthetics innovation - offering solutions ranging from a laser-based cure for acne to an AI platform to optimize aesthetic treatment.
Collectively, these companies are raising a total of $50M.
Presenting LaunchPad SBDC Companies at Aesthetics Tech Summit 2022
Accure Acne, Inc.
Accure Acne will disrupt the vast, global acne market with a unique, proprietary laser treatment delivering safe, long-lasting (durable) results. Co-Founded by Professor Rox Anderson, among the most influential scientists in the field of aesthetic energy-based devices, Accure has built a world-class team and strong IP portfolio. Accure’s unique laser wavelength (1726nm) selectively damages sebaceous glands, which are directly linked to acne production. This yields a drug-free, non-systemic, focal area treatment that reduces recurrence of inflammatory acne lesions in the treated areas. Accure has CE Mark clearance for the EU and is in the midst of its FDA Pivotal Trial.
We have entered the era of regenerative medicine. Clients are leveraging their own cells for anti-aging skin and hair rejuvenation, in-patient trials are underway for cell and gene therapies, and scientists are developing solutions to grow organs on demand.
When it comes to these regenerative treatments, there's a catch and generations alive today are at risk of missing out. As we age, so do our cells, and over time they lose their capability. Acorn has solved this problem, by allowing individuals to freeze their cells - stopping aging and disease - through its patented, safe, and non-invasive live-cell collection, analysis, and cryopreservation service.
Elevai Labs Inc.
ELEVAI Labs utilizes a mixture of biochemical engineering and cutting edge stem cell culture expertise in a proprietary process to generate exosomes. ELEVAI exosomes provide proteins, peptides, and other bio molecules that support and nourish the skin.
By triggering our ultra pure umbilical derived stem cells in vitro, we can capture and concentrate the powerful natural factors they produce and apply them topically, supporting healthy, glowing, naturally balanced skin.
In combination with our ELEVAI exosomes, our topicals also utilize top quality, clinically proven skincare ingredients, including: bioavailable forms of vitamin C, aloe, copper peptides, and hyaluronic acid. Lastly, ELEVAI products are tested rigorously and quantitatively to verify efficacy and ensure confidence.
LoveMyDelta, Inc is a visual knowledge company. The modern world is awash in images, but documenting visual change amongst large populations of aesthetic consumers remains costly and time-consuming. This is largely due to two pain points: image capture and analysis of big data. LoveMyDelta provides a cloud-based software platform that leverages crowdsourcing and AI to provide analytical tools for partners in beauty and aesthetic medicine. The platform includes the LMD iOS app and the LMD web-based visual survey environment. These portals provide for standardized image capture, prompt data labeling, and rapid, cost-effective visual analysis.